Thorium-227-based radioimmunotherapy tested in preclinical studies for the treatment of glioblastoma
Oct. 21, 2022
Investigators have developed α-therapeutic thorium-227-labeled DUNP19 ([227Th]Th-DUNP19), an antibody-conjugated radiopharmaceutical with high specificity and affinity to LRRC15.
